CompletedNCT07155096
Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity
Device studyAges 18–65United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- NashvilleSee all locations and recruitment
Study information
Study start dateStarted: September 9, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 37
- Sponsor
- Vanderbilt University Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07155096
- Official title
Show the full official title
Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity
Get this study by email
Recruitment & locations
CompletedNashville
Questions about this study
Who is behind this study?
The study sponsor is Vanderbilt University Medical Center, a hospital or academic medical center.
Who was this study for?
Listed age limits: 18 years to 65 years.
